LXR agonists reduce intracellular NAD levels through induction of CD38 Activation of LXRs impairs cytoskeletal changes associated with bacterial infection The LXR-CD38 circuit protects host macrophages from extensive bacterial infection Activation of the LXR-CD38 circuit ameliorates clinical signs of infection in vivo